Modern Chinese Medicine Group Co., Ltd.

Company ProfileChairman's SpeechCorporate CultureCorporate QualificationsDevelopment HistoryOrganizational ChartCirculation Enhancement Pill   氣血雙補丸Vigour and Vitality Supplement Pill   補腎填精丸Kidney Invigoration Pill   金匱腎氣丸Menstrual Discomfort Relief Pill   加味逍遙丸Six-Ingredient Rehmannia Pill   六味地黃丸Cinnabar Nerve-calming Pill   朱砂安神丸Anemarrhena, Phellodendron and Rehmannia Pill知柏地黃丸Bazhen Yimu Pill   八母益珍丸Arborvitae Seed Heart Nourishing Pill   柏子養心丸Spleen Invigorating and Qi Replenishing Pill 補中益氣丸Eight-ingredient Rehmannia Pill   麥味地黃丸Lycium, Chrysanthemum and Rehmannia Pill   杞菊地黃丸Tianwang Heartreplenishing Pill   天王補心丸Relief Pill   逍遙丸Six-Ingredient Rehmannia Pill 2   六味地黃丸2Anemarrhena, Phellodendron and Rehmannia Pil知柏地黃丸2QI-DEFICIENCY AND BLOOD-STASIS CONDITIONHeart Wellness Capsule   心安膠囊Cardiotonic Enhancement Capsule   山玫膠囊CARDIO-CEREBROVASCULAR CONDITIONLiver-dispersing and Stomachregulating Pill  舒肝和胃丸Liver Detox Tablet   護肝片Daochi Pill   導赤丸Chinese Goldthread Rhizome Supernatant Pill  黃連上清丸Calculus Bovis Detoxification Pill   牛黃解毒丸Calculus Bovis Supernatant Pill   牛黃上清丸Liver-dispersing and Stomachregulating Pill 舒肝和胃丸2DIGESTIVE AND GASTROINTESTINAL CONDITIONCirculation Enhancement Pill   氣血雙補丸Bazhen Yimu Pill   八珍益母丸Relief Pill   逍遙丸Nutgrass Galingale Rhizome Pill   香附丸GYNAECOLOGICAL CONDITIONAdditional Ingredient Huoxiang ZhengQi Pill加味藿香正氣丸Fever-removing and Detoxification Pill   清瘟解毒丸Tangerine Pill   橘紅丸Lung-ventilating and Lungregulating Pill   通宣理肺丸Yin-nourishing and Lung-cooling Pill   養陰清肺丸Nutgrass Galingale Rhizome Pill   香附丸SYMPTOMS OF COVID-19 SIMILAR ILLNESSSmall Meridianactivating Pill   小活絡丸Dizzinessrelieving Pill   清眩丸OTHERSCompany NewsPolicies and RegulationsGovernance StructureBoard of directorsCorporate GovernanceAnnouncements and NoticeListing documentsAnnouncement and circularReturn of EquityFinancial reportsStock informationInvestor relations liaison
Modern Chinese Medicine Group Co., Ltd.

      Modern Chinese Medicine Group Co., Ltd. is one of the pioneers in modern  Chinese medicine industry. Our principal operating subsidiary, Chengde Yushi Jindan Pharmaceutical Co., Ltd., is a Chinese medicine manufacturing company with a long history.
     Our history can be traced back to 1986. Adhering to the corporate mission of "building a national Chinese medicine business and focusing on the healthy development of national Chinese medicine", we have been focusing on the innovative development of Chinese medicines for the treatment and/or alleviation of (i) Qi-deficiency and blood-stasis condition; (ii) cardio-cerebrovascular condition; (iii) digestive and gastrointestinal condition and (iv) gynaecological condition. We owned 71 Drug Approval Numbers which were associated with 59 types of proprietary Chinese medicine("PCM") products, among which, 45 were included in the National Insurance Medicine List. We were one of the leading companies engaged in the production of Qi-deficiency and blood-stasis PCM pills (補氣補血類中成藥丸) and cardio-cerebrovascular PCM capsules (心腦血管中成藥膠囊) in Northeast, the PRC.

R&D Strength
The group has a research and development center at its headquarters in Chengde City, which is equipped with domestic advanced testing equipment and instruments, and has production workshops that are GMP-compliant, covering the research and development needs of Chinese medicine tablets, capsules, pills and other products. We have entered into collaboration agreements with Heilongjiang University of Chinese Medicine (黑龍江中醫藥大學) and Chengde Medical College (承德醫學院) to jointly develop new product and improve production process.

The R&D center has always adhered to the core values of "life-oriented and health-based", the continuous innovation, and market-oriented R&D philosophy, focusing on products for treatment of Qi-deficiency and blood-stasis condition and cardio-cerebrovascular condition. Relying on the R&D of quality, The Group strives to become a pioneer in modern Chinese medicine industry.



2020-02-27中國網 全國人民萬眾一心、眾志成城打響抗疫阻擊戰至今,已于日前取得階段性成果。隨著確診病例治愈人數的逐步上升,一線醫療團隊根據疫情診療進展情況,廣泛征求相關各省、市名中醫意見建議,向社會公布了推薦指導用藥。據全國新型冠狀...






Modern Chinese Medicine Group Co., Ltd.
Copyright - Modern Chinese Medicine Group Co., Ltd